Diagnostics

Diagnostics-4-Future Conference 2021

Diagnostics-4-Future Conference‘ is the international meeting-place for users and providers from industry and science.

Based on questions in medical care, clinics and laboratories, innovative solutions for new diagnostics are discussed including research and development. The focus is also on solutions for rural areas (point-of-care). Organizer is the international health network BioLAGO. The conference emerged from the DiagNET project.

Expertise

Initiator is the international health network BioLAGO where companies, research institutions and clinics work together on new diagnostics. The conference emerged from the DiagNET project.

 

 

Medical need

The discussed matters are highly user-oriented (physicians, clinicians, laboratories, medical centers). Medical needs and compatibility with user processes (clinical routine) are key factors for the conference.

Patient focus

Especially, patient-oriented solutions regarding health-care in regional hospitals are addressed (e.g. point-of-care-testing).

 

Openness

The conference connects partners worldwide with the 4-country region around Lake Constance (Germany, Switzerland, Austria & Liechtenstein). Past conferences brought together experts from over 15 countries (Europe, USA, Asia).
 

More Information: www.diagnostics4future.org

Programme October 25, 2021

12.00

Pre-conference special:
Matchmaking event with 1-to-1 meetings (only a limited number of tickets available!)

15.30

Registration, welcome coffee, exhibition & networking

16.00

Welcome and introduction by BioLAGO
Dr. Jörg Schickedanz, BioLAGO e.V. / JS_Consulting

Session 1: Digital diagnostics - what are valid business models?

Chair: Dr. Michael Steinwand, BioLAGO / Innovendia Consulting Services (D)

16.10

KEYNOTE
Added value through digital health and related business models
Sebastian Vorberg, Bundesverband Internetmedizin (Federal Association Internet Medicine)

16.35

Networking and exhibition

17.00

Digital approaches to ensure continuity and quality in cancer treatment
Kai Bastian Henning, Roche Diagnostics (CH/D)

17.20

Digital health - viable models from the perspective of medium-sized enterprises
Alexander Gmelin, VidaWell GmbH (D)

17.40

Plenary discussion

17.50

Networking and exhibition

18.30

Conference Dinner with live music (Location: Steigenberger Inselhotel)

 

 

Programme October 26, 2021

 

09.30

Registration, welcome coffee & networking

10.00

Introduction and review of Day 1:
Dr. Michael Steinwand, BioLAGO (D)

Session 2: New diagnostic concepts for infectious diseases

Chair: Dr. Daniel Caminada, LMZ Dr Risch Group (LI/CH)

10.05

KEYNOTE
Looking Beyond PCR: Novel Applications of Molecular Diagnostics to Detect Secondary Bacterial Infections in Patients with Influenza or SARS-CoV-2
Dr. med. Peter Keller, University Hospital of Bern ‘Inselspital‘ (CH)

10.30

Whole genome sequencing of pathogens for infection surveillance

Dr. Oliver Nolte, Center for Laboratory Medicine St. Gallen (CH)

10.50

A microfluidics platform in combination with NGS for ultra-fast notification of Mycobacterium tuberculosis and its resistance pattern
Dr. Markus Beutler, Institute of Microbiology and Laboratory Medicine (D)
Dr. Kerstin Rönsch, Eurofins Genomics Europe Sequencing GmbH (D)

11.10

Decoding the Unknown: Use of Clinical Metagenomics to Effectively Diagnose Infectious Diseases
Prof. Dr. John Rossen, University of Groningen (NL)

11.30

Plenary discussion

11.40

Conference lunch & networking

Session 3: Individual diagnostics - the key factor for immunotherapies in cancer treatment

Chair: Dr. Simone Günther, EMC² Lake Constance / Becton Dickinson (D)

13.00

KEYNOTE

Topic: Cell therapy and the role of diagnostics - review on up-to-date research
Dr. Reuben Benjamin, King's College London (UK)

13.25

Disease-specific T-cell monitoring – a tool to improve cancer immunotherapies
Dr. Lieselotte Brix, Immudex ApS (DK)

13.45

Deep sequencing: needs & challenges from laboratory view
Dr. Sabine Kelkenberg, CeGaT GmbH (D)

14.05

nanoLabelling for stem cell visualization and tracking
Marc Masa, LEITAT Technological Center (ESP)

14.25

Plenary discussion

14.35

Networking, coffee & exhibition

Session 4: Common diseases - needs and new approaches for diagnostics and therapy

Chair: Dr. Emmanuel Delamarche, IBM Research (CH)

15.15

KEYNOTE
Point of Care versus Lab Based testing of common diseases – Striking a balance
Prof. Dr. Orla Sheils, Trinity College Dublin (IRL)

15.40

PANEL DISCUSSION
Healthcare in 2025: everything digital?

Introductory presentation:
Future solutions integrating diagnostics and therapy
Dr. Emmanuel Delamarche, IBM Research (CH)

  • Dr. Andrea Stancati, Takeda Pharmaceuticals International AG (CH)
  • Till Osswald, Microsoft Deutschland GmbH (D)
  • Prof. Dr. Orla Sheils, Trinity College Dublin (IRL)
  • Dr. Ina Wüstefeld, Aesculap AG (D)
  • Dr. med. Volker Liebenberg, Illumina, Inc. (D)
  • Prof. Dr. Ralf Seepold, HTWG Konstanz - University of Applied Sciences (D)

16.40

Closing remarks and networking apéro

Termin

Datum:
25.10.2021–26.10.2021

Zeit:
Uhr

Kosten:
siehe Webseite

Veranstalter

BioLAGO e.V. – the health network
Byk-Gulden-Str. 2
78467 Konstanz (Germany)

Tel. +49 (0)7531 – 921525 0
www.biolago.org | www.diagnet.org

Ort

Konzil Konstanz
Hafenstr. 2
78462 Konstanz

Kontakt

BioLAGO – Das Gesundheitsnetzwerk

Michael Statnik (Konferenzleitung)
Tel. +49 (0)7531 – 921 525 2
Fax +49 (0)7531 – 921 525 9
michael.statnik@biolago.org

Erjia Zhao
Tel. +49 (0)7531 – 921 525 4
Fax +49 (0)7531 – 921 525 9